Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Schratl, P; Sturm, EM; Royer, JF; Sturm, GJ; Lippe, IT; Peskar, BA; Heinemann, A.
Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
EUR J IMMUNOL. 2006; 36(9): 2401-2409.
Doi: 10.1002/eji.200535672
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Böhm Eva
- Heinemann Akos
- Luschnig Petra
- Co-Autor*innen der Med Uni Graz
- Lippe Irmgard Theresia
- Peskar Bernhard
- Royer Julia
- Sturm Gunter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Several chemoattractants can regulate the recruitment of eosinophils to sites of inflammation, but the hierarchy among them is unknown. We observed here that eosinophil chemotaxis towards eotaxin or 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) was amplified up to sixfold in the presence of prostaglandin (PG) D2. This effect was only seen in eosinophils, and not in neutrophils or basophils. Pretreatment with the chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) antagonist ramatroban prevented the PGD2 enhancement of eosinophil migrations. In contrast, eotaxin or 5-oxo-ETE inhibited the migration of eosinophils towards PGD2. 5-oxo-ETE enhanced the chemotaxis to eotaxin, while eotaxin had no effect on 5-oxo-ETE-induced migration. 5-oxo-ETE induced the phosphorylation of p38 mitogen-activated protein kinase, and inhibition of p38 mitogen-activated protein kinase by SB-202190 converted the effect of 5-oxo-ETE on the chemotaxis to PGD2 from inhibition to enhancement. The presence of blood or plasma markedly decreased the sensitivity of eosinophils to eotaxin or 5-oxo-ETE, while responses to PGD2 were unaltered. In conclusion, PGD2 might be an initial chemoattractant, since it maintains its potency in the circulation and augments the responsiveness of eosinophils to other chemoattractants. In contrast, eotaxin seems to be an end-point chemoattractant, since it has reduced efficacy in blood and is capable of down-modulating eosinophil responsiveness to other chemoattractants.
- Find related publications in this database (using NLM MeSH Indexing)
- Arachidonic Acids - immunology
- Carbazoles - pharmacology
- Chemokine CCL11 - pharmacology
- Chemokines, CC - immunology
- Chemotactic Factors, Eosinophil - immunology
- Chemotaxis, Leukocyte - drug effects
- Eosinophils - drug effects
- Humans - drug effects
- Platelet Aggregation Inhibitors - pharmacology
- Prostaglandin D2 - immunology
- Sulfonamides - pharmacology
- p38 Mitogen-Activated Protein Kinases - metabolism
- Find related publications in this database (Keywords)
- asthma
- chemokines
- chemotaxis
- degranulation
- prostaglandins